Biotech - Press Releases

Date	Title	Company
24-Jan-2020	Sirnaomics Advances RNAi-Based Prophylactics and Therapeutics to Battle SARI Caused by 2019-nCoV	Sirnaomics, Inc.
24-Jan-2020	Brooks Life Sciences increases Indianapolis biorepository capacity by 20%	Brooks Life Sciences
24-Jan-2020	Dupixent®▼ (dupilumab), accepted for restricted use within NHS Wales for the treatment of moderate to severe atopic dermatitis in adolescents aged 12 years and over1	Sanofi
24-Jan-2020	Dupixent®▼ (dupilumab) available to treat adolescents with moderate to severe atopic dermatitis in Scotland1	Sanofi
24-Jan-2020	ISM® Makes Annual Adjustments to Seasonal Factors for Manufacturing PMI®, Non-Manufacturing NMI® and Diffusion Indexes	Institute for Supply Management
24-Jan-2020	Sanofi Completes Acquisition of Synthorx, Inc.	Sanofi
24-Jan-2020	Johnson & Johnson Announces $250 Million Commitment to Support Frontline Health Workers, Reaching 100 Million People by 2030	Davos
24-Jan-2020	Exosomics implements NanoFCM’s NanoAnalyzer at its Siena facility to provide advanced extracellular vesicles-focused analytical services	NanoFCM
24-Jan-2020	Anat Hakim to join Lilly as General Counsel	Eli Lilly and Company
24-Jan-2020	Genmab Announces 2019 Net Sales Figures for DARZALEX® (daratumumab) and Achievement of USD 150 Million Sales Milestone in DARZALEX Collaboration with Janssen	Genmab
24-Jan-2020	Global Contract Research Organisation Expands Services with Oracle Argus Cloud	PharSafer
24-Jan-2020	Growing AXON Brighton Team Relocates to Larger New Office	AXON
24-Jan-2020	iOnctura raises EUR 15 million in Series A financing to progress its pipeline into clinical development	iOnctura
24-Jan-2020	European CNS specialist Neuraxpharm strengthens expansion into Austrian market with acquisition of easypharm	Neuraxpharm Group
24-Jan-2020	Risdiplam (RG7916) Pivotal FIREFISH Study Demonstrated Statistically Significant Improvement in Infants with Type 1 Spinal Muscular Atrophy	PTC Therapeutics, Inc
24-Jan-2020	Autolus Announces Proposed Public Offering in the United States	Autolus Therapeutics plc
24-Jan-2020	Autolus Announces Pricing of Public Offering	Autolus Therapeutics plc
24-Jan-2020	CStone announces first patient dosed in the global proof-of-concept study of CS1001 in combination with Bayer's regorafenib	CStone Pharmaceuticals
23-Jan-2020	Researchers at Rush University Medical Center Find That Injecting Influenza Vaccines Into Tumors Triggers Immune System Response	Rush University Medical Center
23-Jan-2020	The Center for Breakthrough Medicines is Building the World's Largest Cell and Gene Therapy Contract Development and Manufacturing Organization (CDMO) to Launch in King of Prussia, PA	The Discovery Labs